CDKN2C and cancer: It was reported that 12-O-tetradecanoylphorbol-13-acetate (TpA), widely used as a protein kinase C (pKC) activator, suppresses the expression of p18 (INK4c) through its promoter, accompanied by the induction of human cancer cell growth.